Utilized for parasitic worm infections to target parasite survival and support internal clearance.
Mechanism of Action
Albendazole causes degenerative changes in the intestinal cells of the parasite by binding to tubulin. This inhibits microtubule assembly and disrupts glucose uptake, leading to energy depletion and death of the parasite.
Route of Administration
Oral
Onset Time
1–2 days
Duration
Weeks to months (half-life of active metabolite)
Contraindications
Hypersensitivity to benzimidazoles, Pregnancy
Severe Adverse Events
Myelosuppression, Hepatotoxicity, Anaphylaxis — requires immediate medical attention
Information related to Albendazole is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
